DM
3-D Matrix, Ltd.
DMTRF · OTC
$2.50 +0.00% (+$0.00)
Market Cap ¥49.9B
P/E Ratio 13.50x
Div. Yield -
ROE 64.07%
Bulios Fair Price
$2.03
18.8% downside
Current Price
$2.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DMTRF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
48 /100
Fair EV/EBITDA 19.15x
P/S 4.16x
P/B 6.96x
Growth
100 /100
Growing Book val. growth 134.71%
Rev. growth 67.47%
FCF growth N/A
Profitability
61 /100
Moderate Net margin 30.83%
Op. margin 15.28%
FCF margin 0.00%
Quality
100 /100
Excellent ROE 64.07%
ROA 39.57%
Asset turnover 1.28x
Debt
100 /100
Low Current ratio 4.08x
Int. coverage 190.45x
Net debt/EBITDA -0.43x
Stability
38 /100
Moderate Rev. volatility 25.77%
EPS volatility 455.10%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DMTRF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Toshihiko Amanuma
Employees
129
Headquarters
Tokyo
Upcoming events
15 DEC
Earnings
Upcoming earnings report